menu
    • menu

    Company profile for Dewpoint Therapeutics

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a dynamic young biotech company based in Boston and Dresden that is translating brand-new insights about biomolecular condensates into treatments for the toughest diseases. Dewpoint strives to cultivate an inclusive international community that welcomes and empowers everyone. We reject racism, discrimination, harassment, brutality, and all other manifestations of hate. Dewpoint Therapeutics is the first company founded ...
    We are a dynamic young biotech company based in Boston and Dresden that is translating brand-new insights about biomolecular condensates into treatments for the toughest diseases. Dewpoint strives to cultivate an inclusive international community that welcomes and empowers everyone. We reject racism, discrimination, harassment, brutality, and all other manifestations of hate. Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that are regulated by condensates.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dewpoint TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6 Tide Street, Suite 300 Boston, MA 02210
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://dewpointx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dewpointtherapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Fast-Tracks Dewpoint's DPTX3186 to Treat Gastric Cancer
    FDA Fast-Tracks Dewpoint's DPTX3186 to Treat Gastric Cancer

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3189301/0/en/FDA-Grants-Fast-Track-Designation-to-Dewpoint-Therapeutics-DPTX3186-for-the-Treatment-of-Gastric-Cancer.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    FDA Grants Orphan Drug Designation to Dewpoint’ DPTX3186
    FDA Grants Orphan Drug Designation to Dewpoint’ DPTX3186

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176579/0/en/FDA-Grants-Orphan-Drug-Designation-to-Dewpoint-Therapeutics-DPTX3186-for-the-Treatment-of-Gastric-Cancer.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Dewpoint Therapeutics Opens IND For WNT-Driven Cancer Condensate
    Dewpoint Therapeutics Opens IND For WNT-Driven Cancer Condensate

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3170240/0/en/Dewpoint-Therapeutics-Announces-an-Open-IND-for-First-in-Class-Condensate-Modulator-DPTX3186-for-Wnt-Driven-Cancers.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    Dewpoint Therapeutics Presents At AACR-NCI-EORTC 2025
    Dewpoint Therapeutics Presents At AACR-NCI-EORTC 2025

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166238/0/en/Dewpoint-Therapeutics-Announces-Presentation-at-AACR-NCI-EORTC-2025.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    Dewpoint Secure Series D Fund for Gastric Cancer Drug Development
    Dewpoint Secure Series D Fund for Gastric Cancer Drug Development

    10 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/10/3148027/0/en/Dewpoint-Therapeutics-Closes-Series-D-Financing-to-Advance-First-in-Class-Condensate-Modulator-c-mod-into-Clinical-Development-for-Gastric-Cancer.html

    GLOBENEWSWIRE
    10 Sep 2025
    Share Share
    Dewpoint Cuts 70% Staff as Cash Depletes
    Dewpoint Cuts 70% Staff as Cash Depletes

    08 Aug 2025

    // BIOSPACE

    https://www.biospace.com/business/dewpoint-slashes-headcount-by-70-as-cash-runway-runs-out

    BIOSPACE
    08 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search